1993
DOI: 10.1021/jm00074a002
|View full text |Cite
|
Sign up to set email alerts
|

Structure-activity relationship within a series of pyrazolidinone antibacterial agents. 2. Effect of side-chain modification on in vitro activity and pharmacokinetic parameters

Abstract: The structure-activity relationship among a series of novel pyrazolidinone antibacterial agents is described. Specifically, the effect of modification of the side chain attached to the nitrogen at C-7 was explored in an attempt to improve the potency and spectrum of activity. This approach was successful in identifying several compounds having good in vitro profiles. These top candidates were then evaluated for their activity in vivo, and their pharmacokinetic behavior in various animal models was explored. Th… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
23
0

Year Published

2008
2008
2019
2019

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 66 publications
(24 citation statements)
references
References 1 publication
1
23
0
Order By: Relevance
“…[8] Next, av ariety of allylic acetals 2b-2g was employed in the reaction with 1a under the optimized reaction conditions, and the results are shown in Table 3. It should be noted that this reaction is not limited to only hetero(aryl) azomethine imines.…”
Section: Angewandte Chemiementioning
confidence: 99%
“…[8] Next, av ariety of allylic acetals 2b-2g was employed in the reaction with 1a under the optimized reaction conditions, and the results are shown in Table 3. It should be noted that this reaction is not limited to only hetero(aryl) azomethine imines.…”
Section: Angewandte Chemiementioning
confidence: 99%
“…The applicability of 40 for the preparation of biologically active peptide mimetics was successfully demonstrated by researchers at Eli Lilly almost three decades ago. [19][20][21][22] Strangely enough, very few other examples of 40-derived compounds have been reported since 1990, meaning that 40 is a practically unexplored scaffold with reasonable applicative potential. The most general and straightforward synthetic approach towards derivatives of 40 includes stereoselective 1,3-dipolar cycloaddition as the key-step and starting from 4-acylamino-3-pyrazolidinones, which in turn are easily available by simple treatment of α,β-dehydro-α-amino acid derivatives with excess hydrazine hydrate.…”
Section: Pyrazolo[12-a]pyrazolesmentioning
confidence: 99%
“…16,17 Bicyclic pyrazolidinones are used, among others, as drugs to relieve Alzheimer's disease 18 and as antibacterial agents. [19][20][21][22][23] Some important 3-pyrazolidinones are presented in (Figure 1). Due to their applicability and biological activity, pyrazolidin-3-one derivatives, both monoand bi-cyclic, remain attractive synthetic targets.…”
Section: Introductionmentioning
confidence: 99%
“…Among bicyclic analogues, perhydropyrazolo[1,2-a]pyrazolones belong to azabicycloalkane amino acids, which are U-shaped conformationally constrained heterocyclic analogues of peptides that simulate β-turn structures. 9,10 Consequently, bicyclic pyrazolidinones are used as drugs to relieve Alzheimer's disease 11 and as antibacterial (Eli-Lilly's γ-lactam antibiotics), 12 and antitrypanosomal agents. 13 Synthetic applications of 3-pyrazolidinones comprise their use as chiral auxiliaries, [14][15][16][17][18][19] as templates in asymmetric Diels-Alder cycloadditions, [20][21][22] and as a new scaffold in organocatalysis.…”
Section: Introductionmentioning
confidence: 99%